دانلود کتاب Blood and Marrow Transplant Handbook 3rd Edition

فهرست مطالب کتاب Blood and Marrow Transplant Handbook 3rd Edition – (کتاب راهنمای پیوند خون و مغز ویرایش سوم-2021):

1. Overview of Hematopoietic Cell Transplantation and Cellular Therapy
2. The Business of Cellular Therapy and Hematopoietic Cell Transplantation
3. Hematopoietic Stem Cell Sources and Donor Selection
4. Pretransplant Assessment for Hematopoietic Cell Transplantation Recipients and Donors
5. Social Work: Evaluation and Social Supports
6. Conditioning Regimens
7. Nutrition
8. Physical and Occupational Therapy
9. Adolescent and Young Adult Concerns
10. Infection Prevention and Prophylaxis
11. Graft-Versus-Host Disease (GvHD) Prophylaxis
12. Transfusion Medicine
13. Anticoagulation and Antiplatelet Guidelines
14. Engraftment
15. Acute Myeloid Leukemia and Allogeneic Hematopoietic Cell Transplant
16. Acute Lymphoblastic Leukemia
17. Hodgkin Lymphoma and Non-Hodgkin Lymphoma
18. Multiple Myeloma
19. HCT for Germ Cell Tumors
20. Hematopoietic Cell Transplant for Myelofibrosis
21. Chronic Myeloid Leukemia
22. Chronic Lymphocytic Leukemia
23. Hematopoietic Cell Transplant for Severe Aplastic Anemia
24. Inherited Disorders
25. Hematopoietic Cell Transplant and Cellular Therapies for Sickle Cell Disease
26. Radiology Pearls for the Transplant Provider
27. Acute Graft-Versus-Host Disease (GvHD)
28. Chronic Graft-Versus-Host Disease
29. Immune Reconstitution
30. Infectious Complications
31. Oral Complications
32. Gastrointestinal Complications
33. Pulmonary Complications
34. Cardiovascular Complications
35. Kidney Disease in Hematopoietic Cell Transplantation
36. Neurological Complications
37. Endocrine Complications Following Hematopoietic Cell Transplantation
38. Thrombotic Microangiopathies
39. Women’s Health Care
40. Men’s Health for Hematopoietic Cell Transplant Patients
41. Psychiatric Complications
42. Graft Failure
43. Second Primary Malignancies
44. Relapse After Hematopoietic Cell Transplantation
45. Safe Pain Management with Opioids in Posttransplant Patients
46. Complementary Medicine: Acupuncture
47. Complementary Medicine: Medications and Supplements
48. Complementary Medicine: Cannabinoids and the Hematopoietic Cell Transplant (HCT) Recipient
49. Management of Neurocognitive Effects and Fatigue During and After Hematopoietic Cell Transplant
50. Palliative Care
51. Long-Term Follow-Up and Survivorship
52. CAR T Cells for Hematologic Malignancies
53. Natural Killer Cell Therapy in Allogeneic Hematopoietic Cell Transplantation
54. Mesenchymal Stromal Cells: Impact on Hematopoietic Cell Transplantation
55. T-Cell Therapeutics: Donor Lymphocyte Infusion, Cytotoxic T-Lymphocyte Infusion, and Other Non-CAR T-Cell Therapies
56. Dendritic Cell Vaccines
57. BiTEs, DARTs, and Peri-Transplant Minimal Residual Disease
58. CAR T Toxicity Management: Cytokine Release Syndrome and Neurotoxicity
59. Molecular Testing for Post-transplant Disease Surveillance
60. Management of Immune Compromised Transplant and Immune Effector Cell Treated Patients in the Setting of the COVID-19 Viral Pandemic: The OHSU Experience